Jan 12, 2026 04:04AM CorMedix (CRMD) PT Lowered to $15 at Leerink Partners

Jan 8, 2026 12:34PM CorMedix (CRMD) PT Lowered to $16 at Truist Securities

Jan 8, 2026 08:08AM CorMedix names Seckler commercial chief, Todisco becomes chairman

Jan 8, 2026 08:02AM CorMedix reports Q4 revenue of $127 million, provides 2026 guidance

Nov 12, 2025 07:36AM CorMedix (CRMD) Tops Q3 EPS by 83c

Oct 21, 2025 09:09AM CorMedix (CRMD) PT Raised to $22 at RBC Capital

Oct 20, 2025 08:55AM D. Boral Capital Upgrades CorMedix (CRMD) to Buy

Oct 20, 2025 07:32AM CorMedix raises 2025 revenue guidance to at least $375 million

Oct 20, 2025 05:08AM CorMedix (CRMD) PT Lowered to $21 at RBC Capital, 'we would be buyers'

Oct 7, 2025 10:26AM CorMedix (CRMD) call put ratio 2.9 calls to 1 put with a focus on November 12 calls

Oct 6, 2025 06:04AM CorMedix (CRMD) files for 6.32M share offering by selling stockholders

Sep 30, 2025 05:18PM CorMedix (CRMD) files for 6.32M share offering by selling stockholders

Sep 29, 2025 08:30AM CorMedix completes enrollment in phase III fungal infection study

Sep 9, 2025 04:03AM Citizens JMP Reiterates Market Outperform Rating on CorMedix (CRMD)

Aug 7, 2025 07:12AM CorMedix to acquire Melinta Therapeutics for $300 million

Aug 7, 2025 07:06AM CorMedix (CRMD) Tops Q2 EPS by 12c, Beats on Revenue

Jul 7, 2025 11:16AM Grabar Law Office Investigates Claims on Behalf of Shareholders of CorMedix Inc. (CRMD) as Securities Fraud Class Action Survives Motion to Dismiss

Jul 3, 2025 08:53AM Grabar Law Office Investigates Claims on Behalf of Shareholders of CorMedix Inc. (CRMD) as Securities Fraud Class Action Survives Motion to Dismiss

Jun 30, 2025 07:31AM D. Boral Capital Downgrades CorMedix (CRMD) to Hold

Jun 30, 2025 06:40AM H.C. Wainwright Initiates Buy Rating on CorMedix (CRMD)

Jun 27, 2025 08:00AM CorMedix (CRMD) Prices $85M Offering

Jun 26, 2025 04:01PM CorMedix (CRMD) announces $85 million public offering

Jun 24, 2025 08:56AM Truist on CorMedix (CRMD): 'News Better Than Expected'

Jun 23, 2025 07:31AM CorMedix (CRMD) Announces Customer Implementation

Jun 20, 2025 10:13AM CorMedix (CRMD) PT Raised to $17 at RBC Capital; 'Outpatient Strength Likely to Continue in 2H'

May 12, 2025 11:36AM Truist Lays Out Prelim Thoughts on Impact to Generic Drugs Amid WH Update on Drug Pricing

May 6, 2025 07:35AM CorMedix (CRMD) Tops Q1 EPS by 16c

Apr 12, 2025 04:00AM Biotech sector Q1 earnings preview from RBC Capital Markets

Apr 8, 2025 07:33AM CorMedix (CRMD) Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance

Mar 25, 2025 12:35PM Rodman & Renshaw Reiterates Buy Rating on CorMedix (CRMD), PT $20, 'weakness today is likely overdone'

Mar 25, 2025 08:20AM CorMedix (CRMD) Tops Q4 EPS by 5c

Mar 7, 2025 06:20AM Leerink Partners Starts CorMedix (CRMD) at Outperform

Jan 13, 2025 07:03AM D. Boral Capital Starts CorMedix (CRMD) at Buy

Jan 7, 2025 07:49AM CorMedix (CRMD) Announces Preliminary Fourth Quarter 2024 Results and Provides Business Update

Dec 19, 2024 10:56AM CorMedix (CRMD) PT Raised to $12 as RBC Capital Sees a 'Supportive Setup for DefenCath into '25'

Dec 19, 2024 08:30AM CorMedix (CRMD) Added to Nasdaq Biotechnology Index

Oct 30, 2024 07:31AM CorMedix (CRMD) Tops Q3 EPS by 6c

Oct 9, 2024 06:24AM JMP Securities Reiterates Market Outperform Rating on CorMedix (CRMD)

Oct 8, 2024 08:02AM CorMedix (CRMD) Enters New Commercial Agreement with Mid-Sized Dialysis Operator

Sep 9, 2024 10:57AM CorMedix (CRMD) Announces New Commercial Agreement

Aug 14, 2024 07:31AM CorMedix (CRMD) Reports In-Line Q2 EPS

Jul 25, 2024 07:12AM CorMedix (CRMD) PT Lowered to $12 at Truist Securities

Jun 18, 2024 08:01AM CorMedix (CRMD) Receives FDA Feedback on Potential Label Expansion